Dehydroepiandrosterone	NN	dehydroepiandrosterone NN PennPOS
has	VBZ	have vdz NUPOS
strong	JJ	strong JJ PennPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
effects	NNS	effect NNS PennPOS
and	CC	and cc NUPOS
is	VBZ	be vbz NUPOS
decreased	VBN	decrease VBN PennPOS
in	IN	in IN PennPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
an	DT	a dt NUPOS
ageing-related	JJ	ageing-related JJ PennPOS
lung	NN	lung NN PennPOS
disorder	NN	disorder NN PennPOS
characterised	VBN	characterize VBN PennPOS
by	IN	by IN PennPOS
expansion	NN	expansion NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
myofibroblast	JJ	myofibroblast JJ PennPOS
population	NN	population NN PennPOS
and	CC	and cc NUPOS
aberrant	JJ	aberrant JJ PennPOS
lung	NN	lung NN PennPOS
remodelling	NN	remodelling NN PennPOS
.	.	. . NUPOS

Dehydroepiandrosterone	NN	dehydroepiandrosterone NN PennPOS
(	(	( ( NUPOS
DHEA	NN	DHEA NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
a	DT	a dt NUPOS
steroid	NN	steroid NN PennPOS
pro-hormone	NN	pro-hormone NN PennPOS
,	,	, , NUPOS
decreases	VBZ	decrease VBZ PennPOS
with	IN	with pp NUPOS
age	NN	age NN PennPOS
but	CC	but cc-acp NUPOS
an	DT	a dt NUPOS
exaggerated	JJ	exaggerated JJ PennPOS
decline	NN	decline NN PennPOS
has	VBZ	have vdz NUPOS
been	VBN	be vbn NUPOS
associated	VBN	associate VBN PennPOS
with	IN	with pp NUPOS
chronic	JJ	chronic JJ PennPOS
degenerative	JJ	degenerative JJ PennPOS
diseases	NNS	disease NNS PennPOS
.	.	. . NUPOS

We	PRP	we pns12 NUPOS
quantified	VBD	quantify VBD PennPOS
the	DT	the dt NUPOS
plasma	NN	plasma NN PennPOS
levels	NNS	level NNS PennPOS
of	IN	of pp-f NUPOS
DHEA	NN	DHEA NN PennPOS
and	CC	and cc NUPOS
its	PRP$	its po31 NUPOS
sulfated	JJ	sulfated JJ PennPOS
form	NN	form NN PennPOS
(	(	( ( NUPOS
DHEA-S	NN	DHEA-S NN PennPOS
)	)	) ) NUPOS
in	IN	in IN PennPOS
137	CD	137 crd NUPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
and	CC	and cc NUPOS
58	CD	58 crd NUPOS
controls	NNS	control NNS PennPOS
and	CC	and cc NUPOS
examined	VBD	examine VBD PennPOS
the	DT	the dt NUPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
DHEA	NN	DHEA NN PennPOS
on	IN	on IN PennPOS
human	JJ	human JJ PennPOS
lung	NN	lung NN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
.	.	. . NUPOS

Plasma	NN	plasma NN PennPOS
DHEA/DHEA-S	NN	DHEA/DHEA-S NN PennPOS
was	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
decreased	VBN	decrease VBN PennPOS
in	IN	in IN PennPOS
male	JJ	male JJ PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
(	(	( ( NUPOS
median	NN	median NN PennPOS
(	(	( ( NUPOS
range	NN	range NN PennPOS
)	)	) ) NUPOS
DHEA	NN	DHEA NN PennPOS
:	:	: : NUPOS
4.4	CD	4.4 CD PennPOS
(	(	( ( NUPOS
0.2-29.2	CD	0.2-29.2 CD PennPOS
)	)	) ) NUPOS
versus	CC	versus pp NUPOS
6.7	CD	6.7 CD PennPOS
(	(	( ( NUPOS
2.1-15.2	CD	2.1-15.2 CD PennPOS
)	)	) ) NUPOS
ng	NN	ng NN PennPOS
mL	NN	ml NN PennPOS
(	(	( ( NUPOS
-1	CD	-1 CD PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.01	CD	0.01 CD PennPOS
;	:	; : NUPOS
DHEA-S	NN	DHEA-S NN PennPOS
:	:	: : NUPOS
47	CD	47 CD PennPOS
(	(	( ( NUPOS
15.0-211	CD	15.0-211 CD PennPOS
)	)	) ) NUPOS
versus	CC	versus pp NUPOS
85.2	CD	85.2 CD PennPOS
(	(	( ( NUPOS
37.6-247.0	CD	37.6-247.0 CD PennPOS
)	)	) ) NUPOS
g	NN	g NN PennPOS
dL	NN	dl NN PennPOS
(	(	( ( NUPOS
-1	CD	-1 CD PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.001	CD	0.001 CD PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
while	IN	while cs NUPOS
in	IN	in IN PennPOS
females	NNS	female NNS PennPOS
only	RB	only av-j NUPOS
DHEA-S	NN	DHEA-S NN PennPOS
was	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
decreased	VBN	decrease VBN PennPOS
(	(	( ( NUPOS
32.6	CD	32.6 CD PennPOS
(	(	( ( NUPOS
15.0-303.0	CD	15.0-303.0 CD PennPOS
)	)	) ) NUPOS
versus	CC	versus pp NUPOS
68.3	CD	68.3 CD PennPOS
(	(	( ( NUPOS
16.4-171	CD	16.4-171 CD PennPOS
)	)	) ) NUPOS
g	NN	g NN PennPOS
dL	NN	dl NN PennPOS
(	(	( ( NUPOS
-1	CD	-1 CD PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.001	CD	0.001 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

DHEA	NN	DHEA NN PennPOS
caused	VBD	cause VBD PennPOS
a	DT	a dt NUPOS
decrease	NN	decrease NN PennPOS
in	IN	in IN PennPOS
fibroblast	NN	fibroblast NN PennPOS
proliferation	NN	proliferation NN PennPOS
and	CC	and cc NUPOS
an	DT	a dt NUPOS
approximately	RB	approximate RB PennPOS
two-fold	JJ	twofold j NUPOS
increase	NN	increase NN PennPOS
in	IN	in IN PennPOS
fibroblast	NN	fibroblast NN PennPOS
apoptosis	NN	apoptosis NN PennPOS
,	,	, , NUPOS
probably	RB	probable av-j NUPOS
through	IN	through IN PennPOS
the	DT	the dt NUPOS
intrinsic	JJ	intrinsic JJ PennPOS
pathway	NN	pathway NN PennPOS
with	IN	with pp NUPOS
activation	NN	activation NN PennPOS
of	IN	of pp-f NUPOS
caspase-9	NN	caspase-9 NN PennPOS
.	.	. . NUPOS

This	DT	this d NUPOS
effect	NN	effect NN PennPOS
was	VBD	be vbd NUPOS
accompanied	VBN	accompany VBN PennPOS
by	IN	by IN PennPOS
upregulation	NN	upregulation NN PennPOS
of	IN	of pp-f NUPOS
several	JJ	several JJ PennPOS
pro-apoptotic	JJ	pro-apoptotic JJ PennPOS
proteins	NNS	protein NNS PennPOS
(	(	( ( NUPOS
Bax	NN	bax NN PennPOS
and	CC	and cc NUPOS
cyclin-dependent	JJ	cyclin-dependent JJ PennPOS
kinase-inhibitor	NN	kinase-inhibitor NN PennPOS
CDNK1A	NN	CDNK1A NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
downregulation	NN	downregulation NN PennPOS
of	IN	of pp-f NUPOS
anti-apoptotic	JJ	anti-apoptotic JJ PennPOS
proteins	NNS	protein NNS PennPOS
,	,	, , NUPOS
such	JJ	such JJ PennPOS
as	IN	as c-acp NUPOS
cellular	JJ	cellular JJ PennPOS
inhibitor	NN	inhibitor NN PennPOS
of	IN	of pp-f NUPOS
apoptosis	NN	apoptosis NN PennPOS
(	(	( ( NUPOS
c-IAP	NN	c-IAP NN PennPOS
)	)	) ) NUPOS
1	CD	1 crd NUPOS
and	CC	and cc NUPOS
c-IAP2	NN	c-IAP2 NN PennPOS
.	.	. . NUPOS

DHEA	NN	DHEA NN PennPOS
also	RB	also av NUPOS
caused	VBD	cause VBD PennPOS
a	DT	a dt NUPOS
significant	JJ	significant JJ PennPOS
decrease	NN	decrease NN PennPOS
of	IN	of pp-f NUPOS
transforming-growth-factor-b1-induced	JJ	transforming-growth-factor-b1-induced JJ PennPOS
collagen	NN	collagen NN PennPOS
production	NN	production NN PennPOS
and	CC	and cc NUPOS
fibroblast	NN	fibroblast NN PennPOS
to	TO	to p-acp NUPOS
myofibroblast	NN	myofibroblast NN PennPOS
differentiation	NN	differentiation NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
inhibited	VBD	inhibit VBD PennPOS
platelet-derived	JJ	platelet-derived JJ PennPOS
growth	NN	growth NN PennPOS
factor-induced	JJ	factor-induced JJ PennPOS
fibroblast	NN	fibroblast NN PennPOS
migration	NN	migration NN PennPOS
.	.	. . NUPOS

These	DT	these d NUPOS
findings	NNS	finding n2 NUPOS
demonstrate	VBP	demonstrate VBP PennPOS
a	DT	a dt NUPOS
disproportionate	JJ	disproportionate JJ PennPOS
decrease	NN	decrease NN PennPOS
of	IN	of pp-f NUPOS
DHEA/DHEA-S	NN	DHEA/DHEA-S NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
and	CC	and cc NUPOS
indicate	VBP	indicate VBP PennPOS
that	IN	that cst NUPOS
this	DT	this d NUPOS
molecule	NN	molecule NN PennPOS
has	VBZ	have vdz NUPOS
multiple	JJ	multiple JJ PennPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
properties	NNS	property NNS PennPOS
.	.	. . NUPOS

